Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 12.09% |
| 3 | Consumer Discretionary | 8.79% |
| 4 | Healthcare | 8.71% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBNK
5626
DELISTED
Territorial Bancorp Inc.
TBNK
| $175K | ﹤0.01% |
20,909
-627
| -3% | -$5.45K |
|
5627
Stem
STEM
$51.2M
| $175K | ﹤0.01% |
24,958
-25,341
| -50% | -$293K |
|
5628
Innovator US Equity Buffer ETF October
BOCT
$289M
| $174K | ﹤0.01% |
4,143
+3,353
| +424% | +$145K |
|
5629
Congress SMid Growth ETF
CSMD
$486M
| $174K | ﹤0.01% |
6,284
+4,291
| +215% | +$127K |
|
|
AVR
5630
Anteris Technologies
AVR
$899M
| $174K | ﹤0.01% |
+47,700
| New | +$307K |
|
|
NVNO
5631
enVVeno Medical
NVNO
$7.7M
| $173K | ﹤0.01% |
1,885
-1,742
| -48% | -$194K |
|
5632
ProShares Ultra Energy
DIG
$82.7M
| $173K | ﹤0.01% |
4,099
+2,647
| +182% | +$104K |
|
5633
Bio-Rad Laboratories Class B
BIO.B
| $172K | ﹤0.01% |
712
| – | – |
|
5634
EPR Properties 9.00% Series E Preferred Shares
EPR.PRE
$112M
| $172K | ﹤0.01% |
5,734
-651
| -10% | -$19.1K |
|
|
RCG
5635
RENN Fund
RCG
$20.3M
| $172K | ﹤0.01% |
67,385
+33,385
| +98% | +$88.7K |
|
5636
Dimensional Inflation-Protected Securities ETF
DFIP
$1.13B
| $172K | ﹤0.01% |
4,079
+4,063
| +25,394% | +$168K |
|
5637
Euroseas
ESEA
$508M
| $172K | ﹤0.01% |
5,604
-1,532
| -21% | -$42.6K |
|
5638
Franklin International Core Dividend Tilt Index ETF
DIVI
$2.76B
| $172K | ﹤0.01% |
5,268
+4,838
| +1,125% | +$155K |
|
5639
Battalion Oil
BATL
$29.9M
| $172K | ﹤0.01% |
131,960
| – | – |
|
5640
Purple Innovation
PRPL
$30.7M
| $171K | ﹤0.01% |
9,033
-6,100
| -40% | -$141K |
|
5641
INNOVATE Corp
VATE
$103M
| $171K | ﹤0.01% |
21,884
+20,656
| +1,682% | +$187K |
|
|
PLTY
5642
YieldMax PLTR Option Income Strategy ETF
PLTY
$403M
| $171K | ﹤0.01% |
+3,000
| New | +$206K |
|
5643
Austin Gold Corp
AUST
$17.5M
| $171K | ﹤0.01% |
131,600
+29,230
| +29% | +$39.1K |
|
5644
Precision Optics
POCI
$46M
| $170K | ﹤0.01% |
41,055
+4,336
| +12% | +$20.6K |
|
5645
EVI Industries
EVI
$184M
| $170K | ﹤0.01% |
10,136
-814
| -7% | -$14.2K |
|
5646
State Street SPDR S&P 500 ESG ETF
EFIV
$1.03B
| $170K | ﹤0.01% |
3,177
| – | – |
|
5647
LifeVantage
LFVN
$83.8M
| $170K | ﹤0.01% |
11,634
-2,102
| -15% | -$39.6K |
|
5648
Achieve Life Sciences
ACHV
$709M
| $169K | ﹤0.01% |
63,138
-13,077
| -17% | -$40.7K |
|
5649
BRC Group Holdings
RILY
$293M
| $168K | ﹤0.01% |
43,458
-56,811
| -57% | -$258K |
|
5650
Acumen Pharmaceuticals
ABOS
$179M
| $168K | ﹤0.01% |
152,636
-113,580
| -43% | -$162K |
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 410 new, 3,433 increased, 3,308 reduced and 270 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 410 new positions and closed 270 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.